Growing GI CRO Alimentiv is a fast-growing specialized GI contract research organization with a global network and a broad end-to-end service offering, presenting opportunities to expand into new therapeutic areas and geographies for pharmaceutical and biotech partners.

IBD Market Lead Trusted by partners for over 70% of all IBD compounds in development, Alimentiv can upsell expanded trial services such as precision medicine, biomarkers, imaging, and real-world evidence to continue supporting IBD programs and adjacent GI indications.

AI powered trials Recent integration of AI imaging, histology endpoints and CDS scoring platforms signals a strong value proposition for sponsors seeking faster, more accurate trial outcomes; pitch opportunities around enhanced data quality, endpoint definition, and operational efficiency.

Global execution With 5,000+ sites across 60+ countries and capabilities spanning clinical operations, imaging, pathology, and real-world data, there is potential to consolidate global trial activation, site management, and cross-regional patient enrollment for multinational studies.

Strategic collaborations Recent partnerships and events indicate openness to co-development and AI-enabled scoring; leverage these relationships to propose joint ventures, expanded study designs, and faster delivery timelines to sponsors prioritizing innovative GI therapeutics.